Mineralys Therapeutics
MLYS
#4701
Rank
A$3.21 B
Marketcap
A$36.42
Share price
3.00%
Change (1 day)
71.32%
Change (1 year)

Mineralys Therapeutics (MLYS) - Total debt

Total debt on the balance sheet as of March 2026 : N/A

According to Mineralys Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Mineralys Therapeutics - Total debt on balance sheet (in 2020)

Total debt by year

Year Total debt Change
2020-12-31A$5.85 M